You're one step closer to unlocking our suite of comprehensive and robust tools.
Fill out the form so we can connect you to the right person.
If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.
Avadel appoints 1st COO
Gauging Supply Chain Risk In Volatile Times
Cannabis: Hashing Out a Budding Industry
IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help
The Market Intelligence Platform
Avadel Pharmaceuticals plc promoted Gregory Divis to be executive vice president and COO, a newly created role at the Dublin-based company.
Divis joined the pharmaceuticals company in January 2017 as chief commercial officer.
He will be responsible for the company's U.S. and European-based operations, including supply chain, business development and commercial operations.